Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
5-Amino-1MQ: Evidence Summary
Evidence summary for 5-Amino-1MQ across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to 5-Amino-1MQ overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Fat metabolism / obesity | Tier C | 1 | NNMT inhibition reduces fat mass in preclinical models; limited human pharmacokinetic data |
| NNMT inhibition | Tier D | 0 | Mechanism well-characterized in vitro; clinical efficacy data pending |